Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123303) titled 'Safety and feasibility of nasal delivery of human dental follicle mesenchymal stem cell-derived exosomes for treatment-resistant schizophrenia with negative symptoms: A pilot study' on April 23.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Zigong Psychiatric Research Center
Condition:
Schizophrenia
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-05-01
Target Sample Size: interventional group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=315195
Published by HT Digital Content Services wit...